Physician profile
John D Doty
NPI 1992786081
$37,151.48
in general payments reported to CMS, 2019-2025
21 companies · $5,307 in 2025
The $5,307 reported for 2025 was more than what 93% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,240 · 2020: $2,022 · 2021: $1,382 · 2022: $6,458 · 2023: $15K · 2024: $4,610 · 2025: $5,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Food and Beverage: $2,302 · Travel and Lodging: $1,427 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $21,000.00 |
| Food and Beverage | $2,302.22 |
| Travel and Lodging | $1,427.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $320.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,749.18 | 2019-2025 | Da Vinci Surgical System |
| Ethicon INC. | $1,105.15 | 2019 | |
| Medtronic, INC. | $465.37 | 2022-2023 | Illumisite |
| Atricure, INC. | $253.87 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Covidien Lp | $76.20 | 2019 | |
| Siemens Medical Solutions USA, INC. | $70.81 | 2021 | |
| Genzyme Corporation | $65.10 | 2022 | |
| Galvanize Therapeutics, INC | $57.26 | 2025 | Aliya System |
| Melinta Therapeutics, LLC | $52.78 | 2021-2022 | |
| Pulmonx Corporation | $38.00 | 2024 | Zephyr Endobronchial Valve |
| Glaxosmithkline, LLC. | $36.78 | 2022-2023 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $24.20 | 2022 | |
| Grifols USA, LLC | $22.18 | 2020 | |
| Baxter Healthcare | $22.02 | 2023 | Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $20.37 | 2023 | Arikayce |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.35 | 2021 | |
| United Therapeutics Corporation | $18.98 | 2023 | Tyvaso |
| Astrazeneca Pharmaceuticals Lp | $16.00 | 2022 | |
| Boston Scientific Corporation | $12.94 | 2022 | |
| Merck Sharp & Dohme LLC | $12.70 | 2019 | |
| Fisher & Paykel Healthcare INC | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.